(Total Views: 454)
Posted On: 05/26/2020 12:01:14 PM
Post# of 154968
The COVID trials are the only thing really moving right now. I'm guessing we may hear the BLA was accepted and is officially under FDA review. With Lalezari on the call, I suppose we could get some good news on eIND because he was beating that drum a few weeks ago.
Otherwise, we're just hanging in there while waiting on the trial results for COVID and the publication of the paper. IMO, we won't hear anything you don't know about the other indications (particularly NASH, GvHD, MS, mono). I'll believe real, binding and favorable financing when I see- been talking about that for years and have mentioned dozens of term sheets that were never signed at this point. Uplisting won't happen until a couple of months after we have that financing.
Enroll, enroll, enroll. That's the name of the game now.
Otherwise, we're just hanging in there while waiting on the trial results for COVID and the publication of the paper. IMO, we won't hear anything you don't know about the other indications (particularly NASH, GvHD, MS, mono). I'll believe real, binding and favorable financing when I see- been talking about that for years and have mentioned dozens of term sheets that were never signed at this point. Uplisting won't happen until a couple of months after we have that financing.
Enroll, enroll, enroll. That's the name of the game now.
(2)
(0)
